Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LY6E |
| Upstream (Parents) |
|---|
| (<<) ST3GAL6 → LY6E |
| (<<) IFIT1 → LY6E |
| (<<) NUDT6 → LY6E |
| (<<) C19orf66 → LY6E |
| (<<) MCOLN1 → LY6E |
| Downstream (Children) |
|---|
| LY6E → ANKMY1 (>>) |
| LY6E → HOXD3 (>>) |
| LY6E → C14orf102 (>>) |
| LY6E → OSBPL1A (>>) |
| LY6E → OASL (>>) |
| LY6E → SPAG11A (>>) |
| LY6E → BAG2 (>>) |
| LY6E → CG030 (>>) |
| LY6E → FDXR (>>) |
| LY6E → NACAP1 (>>) |
| LY6E → LOC100132247///NPIPL3 (>>) |
| LY6E → TP53TG3B///TP53TG3 (>>) |
| LY6E → SMAD4 (>>) |
| LY6E → RSPH6A (>>) |
